SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24 | -22.6% | 1,042 | -12.0% | 0.00% | – |
| Q2 2023 | $31 | +10.7% | 1,184 | +8.3% | 0.00% | – |
| Q1 2023 | $28 | -9.7% | 1,093 | -7.7% | 0.00% | – |
| Q4 2022 | $31 | -99.9% | 1,184 | -5.7% | 0.00% | – |
| Q3 2022 | $36,000 | -96.1% | 1,255 | -96.7% | 0.00% | -100.0% |
| Q2 2022 | $935,000 | -61.7% | 37,968 | -12.2% | 0.01% | -58.8% |
| Q1 2022 | $2,440,000 | -20.1% | 43,234 | -12.3% | 0.02% | -22.7% |
| Q4 2021 | $3,054,000 | -31.3% | 49,273 | -8.7% | 0.02% | -37.1% |
| Q2 2021 | $4,446,000 | 0.0% | 53,948 | 0.0% | 0.04% | 0.0% |
| Q1 2021 | $4,446,000 | 0.0% | 53,948 | 0.0% | 0.04% | 0.0% |
| Q4 2020 | $4,446,000 | 0.0% | 53,948 | 0.0% | 0.04% | 0.0% |
| Q3 2020 | $4,446,000 | 0.0% | 53,948 | 0.0% | 0.04% | 0.0% |
| Q2 2020 | $4,446,000 | 0.0% | 53,948 | 0.0% | 0.04% | 0.0% |
| Q1 2020 | $4,446,000 | 0.0% | 53,948 | 0.0% | 0.04% | 0.0% |
| Q4 2019 | $4,446,000 | 0.0% | 53,948 | 0.0% | 0.04% | 0.0% |
| Q3 2019 | $4,446,000 | 0.0% | 53,948 | 0.0% | 0.04% | 0.0% |
| Q2 2019 | $4,446,000 | 0.0% | 53,948 | 0.0% | 0.04% | 0.0% |
| Q1 2019 | $4,446,000 | – | 53,948 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $71,239,818 | 7.97% |
| Finepoint Capital LP | 556,928 | $12,876,175 | 6.41% |
| M28 Capital Management LP | 197,700 | $4,570,824 | 5.24% |
| Boxer Capital, LLC | 3,421,541 | $79,106,028 | 4.21% |
| Deep Track Capital, LP | 3,546,435 | $81,993,577 | 3.16% |
| EcoR1 Capital, LLC | 3,460,208 | $80,000,009 | 2.70% |
| Orbimed Advisors | 3,968,588 | $91,753,755 | 1.95% |
| Artal Group S.A. | 1,816,620 | $42,000 | 1.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 319,911 | $7,396,342 | 1.35% |
| Perceptive Advisors | 1,520,416 | $35,152,017 | 1.17% |